TEST | IGF-1 | H-FABP | O2 saturation |
---|---|---|---|
ROC curve | |||
AUC | 0.849 | 0.9473 | 0.7618 |
St. error | 0.03811 | 0.02612 | 0.04817 |
95% CI | 0.7743–0.9237 | 0.8961–0.9985 | 0.6674–0.8562 |
P-value | P < 0.0001 |  |  |
Prognostic threshold | > 25.5 ng/mL | > 19.5 ng/mL | < 94.5% |
Sensitivity | 73.44% (95% CI 61.52–82.70%) | 96.88% (95% CI 89.30–99.44%) | 73.44% (95% CI 61.52–82.70%) |
Specificity | 79.07% (95% CI 64.79–88.58%) | 90.7% (95% CI 78.40–96.32%) | 72.09% (95% CI 57.31–83.25%) |
Fisher’s exact test | |||
PPV | 79.07% (95% CI 0.6479–0.8858) | 90.70% (95% CI 0.7840–0.9632) | 72.09% (95% CI 0.5731–0.8325) |
NPV | 72.13% (95% CI 0.5983–0.8181) | 96.88% (95% CI 0.8930–0.9944) | 73.44% (95% CI 0.6152–0.8270) |
Sensitivity | 66.67% (95% CI 0.5297–0.7803) | 95.12% (95% CI 0.8386–0.9913) | 64.58% (95% CI 0.5044–0.7657) |
Specificity | 83.02% (95% CI 0.7077–0.9080) | 93.94% (95% CI 0.8543–0.9762) | 79.66% (95% CI 0.6773–0.8796) |
Relative risk | 2.837 (95% CI 1.883–4.443) | 29.02 (95% CI 8.445–105.6) | 2.714 (95% CI 1.764–4.302) |
Odds ratio | 9.778 (95% CI 3.970–23.29) | 302.3 (95% CI 48.56–1386) | 7.142 (95% CI 2.9–16.76) |